Skip to content

THERALINK TECHNOLOGIES, INC.

CIK 0001362703

← back to feed
Revenue (TTM)
$511.48K
+6.8% YoY Q1 Feb 2024
Net Income (TTM)
−$59.57M
−142.6% YoY Q1 Feb 2024
EPS Diluted (TTM)
−$0.01
Q1 Feb 2024
Gross Margin
72.8%
Q1 Feb 2024
Operating Margin
-1,601.4%
Q1 Feb 2024
Net Margin
-11,646.5%
Q1 Feb 2024
Free Cash Flow (TTM)
−$5.8M
Q1 Feb 2024
Cash
$38.56K
Q1 Feb 2024
Total Debt
$350K
Q1 Feb 2024
Shares Outstanding
6.15B sh
Q1 Feb 2024

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings